Pantothenic acid, acute ethanol consumption and sulphadimidine acetylation
- PMID: 2318546
Pantothenic acid, acute ethanol consumption and sulphadimidine acetylation
Abstract
The effect of pantothenic acid and acute ethanol loading on the genetically determined N-acetyltransferase activity has been studied using sulphadimidine as a test substance. The administration of 1100 mg pantothenic acid daily (600 mg orally, 500 mg iv) for seven days did not significantly alter sulphadimidine kinetics in the primarily elderly 21 subjects we investigated. Acute ethanol loading (0.73 g/kg pure alcohol at start and 0.11 g/kg pure alcohol hourly for 8 hours afterwards, stock solution: 20% v/v ethanol in fruit juice) did not change sulphadimidine acetylation in 10 healthy male volunteers. It is concluded that despite theoretical assumptions exogenous factors like pantothenic acid and ethanol do not significantly influence the cytosolic N-acetyltransferase activity. Consequently they do not interfere with the acetylator phenotyping procedure.
Similar articles
-
Acetylator phenotype in patients with lung carcinoma--a negative report.Eur J Respir Dis. 1985 Jul;67(1):17-9. Eur J Respir Dis. 1985. PMID: 4054252
-
Drug acetylator phenotypes in newborn infants.Biol Res Pregnancy Perinatol. 1987;8(1 1ST Half):23-5. Biol Res Pregnancy Perinatol. 1987. PMID: 3580445
-
Relationship between in vivo acetylator phenotypes and cytosolic N-acetyltransferase and O-acetyltransferase activities in human uroepithelial cells.Cancer Epidemiol Biomarkers Prev. 1994 Jan-Feb;3(1):25-32. Cancer Epidemiol Biomarkers Prev. 1994. PMID: 8118381
-
Caffeine as a potential indicator for acetylator status.J Clin Pharm Ther. 1987 Feb;12(1):47-51. J Clin Pharm Ther. 1987. PMID: 3449563
-
Acetylator phenotyping with sulphadimidine in patients receiving isoniazid.Int J Clin Pharmacol Res. 1984;4(2):141-4. Int J Clin Pharmacol Res. 1984. PMID: 6469440
Cited by
-
The effects of acute ethanol intake on isoniazid pharmacokinetics.Eur J Clin Pharmacol. 2004 Nov;60(9):679-82. doi: 10.1007/s00228-004-0828-y. Epub 2004 Oct 2. Eur J Clin Pharmacol. 2004. PMID: 15568141 Clinical Trial.